This live, case‐based activity targets health care gaps related to the underlying autoimmune causes of alopecia areata (AA) and targeted treatment approaches, which can have a profound impact on health‐related quality of life through burden of disease and associated comorbidities.
This activity will cover the treatment and management of patients locally-advanced or metastatic urothelial carcinoma.
This live, case‐based activity targets health care gaps related to the underlying autoimmune causes of alopecia areata (AA) and targeted treatment approaches, which can have a profound impact on health‐related quality of life through burden of disease and associated comorbidities.
This live, case-based activity will explore the role of screening and surveillance for patients with esophageal cancer (EC) and review clinical trial data on the efficacy and safety of immune checkpoint inhibitors as adjuvant treatment and across lines of therapy.
This live activity will cover early detection and intervention in cancer.
This live, case-based activity will explore the role of screening and surveillance for patients with esophageal cancer (EC) and review clinical trial data on the efficacy and safety of immune checkpoint inhibitors as adjuvant treatment and across lines of therapy.
This activity will cover the treatment and management of patients locally-advanced or metastatic urothelial carcinoma.
This live, case‐based activity targets health care gaps related to the underlying autoimmune causes of alopecia areata (AA) and targeted treatment approaches, which can have a profound impact on health‐related quality of life through burden of disease and associated comorbidities.
This live, case-based activity will explore the role of screening and surveillance for patients with esophageal cancer (EC) and review clinical trial data on the efficacy and safety of immune checkpoint inhibitors as adjuvant treatment and across lines of therapy.
This activity will cover the treatment and management of patients with psoriatic arthritis during the COVID-19 pandemic.
This activity will cover the treatment and management of patients locally-advanced or metastatic urothelial carcinoma.
Fill out your Evaluation Form
